1. Home
  2. PNRG vs CMPX Comparison

PNRG vs CMPX Comparison

Compare PNRG & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PNRG

PrimeEnergy Resources Corporation

N/A

Current Price

$217.35

Market Cap

344.8M

Sector

Energy

ML Signal

N/A

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.38

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNRG
CMPX
Founded
1973
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.8M
408.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
PNRG
CMPX
Price
$217.35
$2.38
Analyst Decision
Hold
Strong Buy
Analyst Count
1
9
Target Price
$160.00
$14.57
AVG Volume (30 Days)
72.8K
2.9M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.57
N/A
Revenue
$189,052,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.18
$934.41
P/E Ratio
$47.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$126.40
$1.61
52 Week High
$278.90
$6.88

Technical Indicators

Market Signals
Indicator
PNRG
CMPX
Relative Strength Index (RSI) 64.80 52.79
Support Level $202.23 $1.82
Resistance Level $227.63 $2.51
Average True Range (ATR) 10.50 0.13
MACD 0.27 -0.01
Stochastic Oscillator 57.39 45.71

Price Performance

Historical Comparison
PNRG
CMPX

About PNRG PrimeEnergy Resources Corporation

PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: